Review: taking Adderall xr 30 and Latuda together


Summary

Drug interactions are reported among people who take Adderall xr 30 and Latuda together. This review analyzes the effectiveness and drug interactions between Adderall xr 30 and Latuda. It is created by eHealthMe based on reports of 25 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Adderall xr 30 and Latuda >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Adderall Xr 30

Adderall xr 30 has active ingredients of amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate. It is often used in attention deficit hyperactivity disorder. (latest outcomes from Adderall xr 30 1,138 users)

Latuda

Latuda has active ingredients of lurasidone hydrochloride. It is often used in schizophrenia. (latest outcomes from Latuda 827 users)

On Aug, 18, 2016

25 people who take Adderall Xr 30, Latuda are studied.


Number of reports submitted per year:

Adderall xr 30 and Latuda drug interactions.

Drug effectiveness over time:

Adderall Xr 30:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 2 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 4 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 100.0% - (1 of 1 people)
  • not specified: 100.0% - (1 of 1 people)
Latuda:
  • < 1 month: 100.0% - (1 of 1 people)
  • 1 - 6 months: 25.0% - (1 of 4 people)
  • 6 - 12 months: 50.0% - (1 of 2 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 100.0% - (2 of 2 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 100.0% - (1 of 1 people)

Drug effectiveness by gender:

Adderall Xr 30:
  • female: 36.0% - (4 of 11 people)
  • male: 0.0% - (0 of 0 people)
Latuda:
  • female: 60.0% - (6 of 10 people)
  • male: 0.0% - (0 of 0 people)

Drug effectiveness by age:

Adderall Xr 30:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 50.0% - (1 of 2 people)
  • 30-39: 25.0% - (1 of 4 people)
  • 40-49: 33.0% - (1 of 3 people)
  • 50-59: 50.0% - (1 of 2 people)
  • 60+: 0.0% - (0 of 0 people)
Latuda:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 50.0% - (1 of 2 people)
  • 30-39: 66.0% - (2 of 3 people)
  • 40-49: 66.0% - (2 of 3 people)
  • 50-59: 50.0% - (1 of 2 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • nausea
  • insomnia
  • mood swings
  • abnormal weight gain
  • acne
  • blood testosterone decreased
  • dizziness
  • dyskinesia
  • dysphagia
  • dyspnoea
1 - 6 months:
  • death
  • acne
  • eyes - dry
  • weight increased
  • hunger
  • migraine
6 - 12 months:
  • weight increased
  • anxiety
  • blurred vision
  • cognitive disorder
  • confusion
  • depression aggravated
  • dry mouth
  • dry skin
  • fatigue
  • fatigue - chronic
1 - 2 years:
  • death
2 - 5 years:
  • inability to crawl
  • cognitive disorder
  • fatigue - chronic
  • hunger
  • memory loss
  • migraine
5 - 10 years:
  • headache - mixed tension migraine
  • numbness in hands or feet
  • anxiety
  • blurred vision
  • confusion
  • depression aggravated
  • dry mouth
  • dry skin
  • fatigue
  • hallucinations, mixed
10+ years:
  • acne
  • eyes - dry
not specified:
  • weight increased
  • amenorrhoea
  • nausea
  • blood testosterone decreased
  • confusional state
  • dizziness
  • drug administration error
  • dyspnoea
  • dystonia
  • erythema

Most common drug interactions by gender *:

female:
  • weight increased
  • acne
  • amenorrhoea
  • eyes - dry
  • migraine
  • confusional state
  • drug administration error
  • erythema
  • hostility
  • rash pruritic
male:
  • nausea
  • blood testosterone decreased
  • death
  • dyspnoea
  • dystonia
  • insomnia
  • mood swings
  • muscle spasms
  • night sweats
  • oedema peripheral

Most common drug interactions by age *:

20-29:
  • death
  • acne
  • eyes - dry
  • weight increased
  • agitation
  • homicidal ideation
  • impatience
  • insomnia
  • mood swings
30-39:
  • amenorrhoea
  • weight increased
  • abnormal weight gain
  • acne
  • cognitive disorder
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • fatigue - chronic
  • memory loss
  • muscle stiffness
  • sweating increased
40-49:
  • weight increased
  • blood testosterone decreased
  • dyspnoea
  • dystonia
  • muscle spasms
  • nausea
  • night sweats
  • oedema peripheral
  • sinus disorder
  • throat tightness
50-59:
  • arthralgia
  • bipolar 1
  • deep vein thrombosis
  • dizziness
  • dysphonia
  • epicondylitis
  • gait disturbance
  • heart rate increased
  • hunger
  • hypotension

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Adderall xr 30 and Latuda?

Can you answer these questions?

More questions for: Adderall xr 30, Latuda

You may be interested in these reviews

More reviews for: Adderall xr 30, Latuda

On eHealthMe, Adderall xr 30 (amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate) is often used to treat attention deficit hyperactivity disorder. Latuda (lurasidone hydrochloride) is often used to treat schizophrenia. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.